🔗 Visit the ClinicalTrials.gov page for NCT00498225
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. | J Clin Oncol | 1997 | 29.02 |
| 2 | Advanced pancreatic carcinoma: current treatment and future challenges. | Nat Rev Clin Oncol | 2010 | 5.07 |
| 3 | Randomized phase III study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: GEST study. | J Clin Oncol | 2013 | 3.26 |
| 4 | An early phase II study of S-1 in patients with metastatic pancreatic cancer. | Oncology | 2005 | 1.21 |
| 5 | A phase I study of combination chemotherapy with gemcitabine and oral S-1 for advanced pancreatic cancer. | Oncology | 2005 | 0.89 |